Dr. Clump is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5230 Centre Ave
Pittsburgh, PA 15232Phone+1 412-623-6720
Education & Training
UPMC Medical EducationResidency, Radiation Oncology, 2009 - 2013
West Virginia UniversityInternship, Transitional Year, 2008 - 2009- West Virginia University School of MedicineClass of 2008
Certifications & Licensure
WV State Medical License 2022 - 2026
PA State Medical License 2009 - 2022- American Board of Radiology Radiation Oncology
Clinical Trials
- Fractionated Stereotactic Radiosurgery for Large Brain Metastases Start of enrollment: 2013 Jul 16
- SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN Start of enrollment: 2013 Jul 03
- An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 97 citationsA Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Car...John A. Vargo, Robert L. Ferris, James Ohr, David A. Clump, Kara S. Davis
International Journal of Radiation Oncology, Biology, Physics. 2015-03-01 - 153 citationsPD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck CancerBenjamin A. Kansy, Fernando Concha-Benavente, Raghvendra M. Srivastava, Hyun-Bae Jie, Gulidanna Shayan
Cancer Research. 2017-11-15 - 108 citationsCirculating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.Marie-Nicole Theodoraki, Saigopalakrishna S. Yerneni, William E. Gooding, James Ohr, David A. Clump
Oncoimmunology. 2019-04-24
Press Mentions
YOUR HEALTH: Using a Tracer to Pinpoint Cancerous TumorsOctober 1st, 2021
Revolutionary Laser Light Therapy Helping Cancer Patients Undergoing ChemotherapyDecember 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
